The physicians and patients involved in the early advancement of treatments for pediatric cardioskeletal myopathies have long been regarded as "passionate risk-takers." With each new procedure creating room for innovation and the robust incorporation of science related to clinical and surgical outcomes, the morbidity and mortality of pediatric heart disease has continued to decline; it is now often regarded as a chronic medical condition instead of a terminal diagnosis. However, as with any disease process, appropriate and innovative treatments rely entirely on accurate diagnoses. In this chapter, we will discuss current and emerging diagnostic strategies for pediatric heart disease that promise to further advance the field. Although there are myriad innovative advances being made to refine and enhance diagnostic accuracy in pediatric heart disease, we will focus on five main areas: noninvasive imaging, electrophysiology, invasive procedures, monitoring in the cardiac intensive care unit, and genetics.
|Original language||English (US)|
|Title of host publication||Cardioskeletal Myopathies in Children and Young Adults|
|Number of pages||19|
|State||Published - Jan 1 2017|
ASJC Scopus subject areas